Free Trial

NRx Pharmaceuticals (NRXP) Competitors

$2.38
-0.12 (-4.80%)
(As of 07/17/2024 ET)

NRXP vs. HOFV, ACAB, TIL, CMRX, SPRO, AVTE, LSB, DRRX, PMN, and SRZN

Should you be buying NRx Pharmaceuticals stock or one of its competitors? The main competitors of NRx Pharmaceuticals include Hall of Fame Resort & Entertainment (HOFV), Atlantic Coastal Acquisition Corp. II (ACAB), Instil Bio (TIL), Chimerix (CMRX), Spero Therapeutics (SPRO), Aerovate Therapeutics (AVTE), Lakeshore Biopharma (LSB), DURECT (DRRX), ProMIS Neurosciences (PMN), and Surrozen (SRZN).

NRx Pharmaceuticals vs.

Hall of Fame Resort & Entertainment (NASDAQ:HOFV) and NRx Pharmaceuticals (NASDAQ:NRXP) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, community ranking, dividends and valuation.

Hall of Fame Resort & Entertainment has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, NRx Pharmaceuticals has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

3.6% of Hall of Fame Resort & Entertainment shares are held by institutional investors. Comparatively, 4.3% of NRx Pharmaceuticals shares are held by institutional investors. 59.9% of Hall of Fame Resort & Entertainment shares are held by company insiders. Comparatively, 21.1% of NRx Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, NRx Pharmaceuticals had 1 more articles in the media than Hall of Fame Resort & Entertainment. MarketBeat recorded 2 mentions for NRx Pharmaceuticals and 1 mentions for Hall of Fame Resort & Entertainment. NRx Pharmaceuticals' average media sentiment score of 1.93 beat Hall of Fame Resort & Entertainment's score of 1.43 indicating that Hall of Fame Resort & Entertainment is being referred to more favorably in the media.

Company Overall Sentiment
Hall of Fame Resort & Entertainment Very Positive
NRx Pharmaceuticals Positive

NRx Pharmaceuticals has a net margin of 0.00% compared to NRx Pharmaceuticals' net margin of -256.43%. Hall of Fame Resort & Entertainment's return on equity of 0.00% beat NRx Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Hall of Fame Resort & Entertainment-256.43% -45.50% -13.92%
NRx Pharmaceuticals N/A N/A -260.31%

NRx Pharmaceuticals has lower revenue, but higher earnings than Hall of Fame Resort & Entertainment. NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than Hall of Fame Resort & Entertainment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hall of Fame Resort & Entertainment$24.13M0.81-$68.68M-$10.78-0.28
NRx PharmaceuticalsN/AN/A-$30.15M-$3.14-0.76

Hall of Fame Resort & Entertainment received 1 more outperform votes than NRx Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave NRx Pharmaceuticals an outperform vote while only 90.00% of users gave Hall of Fame Resort & Entertainment an outperform vote.

CompanyUnderperformOutperform
Hall of Fame Resort & EntertainmentOutperform Votes
9
90.00%
Underperform Votes
1
10.00%
NRx PharmaceuticalsOutperform Votes
8
100.00%
Underperform Votes
No Votes

NRx Pharmaceuticals has a consensus price target of $43.00, suggesting a potential upside of 1,706.72%. Given Hall of Fame Resort & Entertainment's higher possible upside, analysts clearly believe NRx Pharmaceuticals is more favorable than Hall of Fame Resort & Entertainment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hall of Fame Resort & Entertainment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
NRx Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

NRx Pharmaceuticals beats Hall of Fame Resort & Entertainment on 9 of the 16 factors compared between the two stocks.

Get NRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRXP vs. The Competition

MetricNRx PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$25.47M$7.21B$5.31B$8.53B
Dividend YieldN/A2.75%2.76%4.02%
P/E Ratio-0.7620.95137.8218.61
Price / SalesN/A483.062,137.90106.73
Price / CashN/A33.3235.4333.66
Price / Book-1.725.934.984.55
Net Income-$30.15M$147.02M$110.66M$216.32M
7 Day Performance0.85%6.28%5.37%5.84%
1 Month Performance-22.48%8.24%8.10%7.15%
1 Year Performance-93.90%-1.57%6.30%3.52%

NRx Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HOFV
Hall of Fame Resort & Entertainment
0 of 5 stars
0.00 / 5 stars
$3.02
+2.7%
N/A-70.7%$19.72M$24.13M-0.2898Positive News
High Trading Volume
ACAB
Atlantic Coastal Acquisition Corp. II
0 of 5 stars
0.00 / 5 stars
$12.39
flat
N/A+5.6%$101.23MN/A0.004Positive News
Gap Up
High Trading Volume
TIL
Instil Bio
2.7812 of 5 stars
2.78 / 5 stars
$12.72
+31.1%
$25.00
+96.5%
+3.2%$82.73MN/A-0.67410Gap Up
High Trading Volume
CMRX
Chimerix
3.8678 of 5 stars
3.87 / 5 stars
$0.90
+2.3%
$8.50
+846.0%
-20.1%$80.53M$320,000.00-0.9790Gap Down
SPRO
Spero Therapeutics
4.5566 of 5 stars
4.56 / 5 stars
$1.42
+2.2%
$7.00
+394.7%
-2.0%$76.40M$103.78M3.29150Positive News
AVTE
Aerovate Therapeutics
3.6146 of 5 stars
3.61 / 5 stars
$1.81
-3.7%
$2.25
+24.3%
-88.4%$52.16MN/A-0.6020Positive News
LSB
Lakeshore Biopharma
0 of 5 stars
0.00 / 5 stars
$0.47
+2.2%
N/AN/A$43.77M$100M0.00773Gap Down
DRRX
DURECT
3.1296 of 5 stars
3.13 / 5 stars
$1.38
+5.3%
$27.50
+1,892.8%
-71.1%$42.83M$8.32M-1.4580Short Interest ↑
PMN
ProMIS Neurosciences
2.0687 of 5 stars
2.07 / 5 stars
$2.25
+6.6%
$8.00
+255.6%
-65.3%$42.66M$10,000.00-3.045Gap Up
SRZN
Surrozen
0 of 5 stars
0.00 / 5 stars
$9.23
-5.5%
N/A-17.5%$29.54M$12.50M0.0080Positive News
High Trading Volume

Related Companies and Tools

This page (NASDAQ:NRXP) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners